المؤلفون: Ijselstein, Marieke, Brouwer, Thomas, Abdulrahman, Ziena, Reidy, Eileen, Ramalheiro, Ana, Heeren, AM, Vahrmeijer, Alexander, Jordanova, ES, de Miranda, Noel

المساهمون: Medical oncology laboratory, CCA - Cancer biology and immunology, AII - Cancer immunology, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D)

المصدر: The Journal of Pathology: Clinical Research, 5(1), 3-11. Wiley-Blackwell Publishing Ltd
Ijselstein, M, Brouwer, T, Abdulrahman, Z, Reidy, E, Ramalheiro, A, Heeren, AM, Vahrmeijer, A, Jordanova, ES & de Miranda, N 2019, ' Cancer immunophenotyping by 7 colour multispectral imaging without tyramide signal amplification ', The Journal of Pathology: Clinical Research, vol. 5, no. 1, pp. 3-11 . https://doi.org/10.1002/cjp2.113

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::24ced3803ab34effc8eb26b026ed5cba
https://research.vumc.nl/en/publications/22bccedf-3cf0-413d-a9c2-6a6dcdb93bfc

المؤلفون: Heeren AM; Cancer Center Amsterdam - Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Rotman J; Cancer Center Amsterdam - Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Center for Gynecologic Oncology (CGOA), Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Samuels S; Center for Gynecologic Oncology Amsterdam (CGOA), AVL NKI, Amsterdam, The Netherlands., Zijlmans HJMAA; Center for Gynecologic Oncology Amsterdam (CGOA), AVL NKI, Amsterdam, The Netherlands., Fons G; Center for Gynecologic Oncology (CGOA), Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., van de Vijver KK; Department of Pathology, University Hospital Ghent, Gent, Belgium., Bleeker MCG; Department of Pathology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Kenter GG; Center for Gynecologic Oncology (CGOA), Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Center for Gynecologic Oncology Amsterdam (CGOA), AVL NKI, Amsterdam, The Netherlands.; Center for Gynecologic Oncology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands., Jordanova EJ; Department of Obstetrics and Gynecology, Center for Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC - Locatie VUMC, Amsterdam, The Netherlands., de Gruijl TD; Cancer Center Amsterdam - Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands td.degruijl@amsterdamumc.nl.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Oct; Vol. 9 (10).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Lymph Nodes/*pathology , Lymphatic Metastasis/*immunology , Vulvar Neoplasms/*immunology, Adult ; Aged ; Female ; Humans ; Middle Aged ; Neoplasm Metastasis ; Tumor Microenvironment

المؤلفون: Rotman J; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam University Medical Center (UMC), Cancer Center Amsterdam (CCA), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Department of Medical Oncology Amsterdam UMC, Cancer Center Amsterdam (CCA), Vrije Universiteit Amsterdam, Amsterdam, Netherlands., den Otter LAS; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam University Medical Center (UMC), Cancer Center Amsterdam (CCA), Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Bleeker MCG; Department of Pathology, Cancer Center Amsterdam (CCA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Samuels SS; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam University Medical Center (UMC), Cancer Center Amsterdam (CCA), Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Heeren AM; Department of Medical Oncology Amsterdam UMC, Cancer Center Amsterdam (CCA), Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Roemer MGM; Department of Pathology, Cancer Center Amsterdam (CCA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Kenter GG; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam University Medical Center (UMC), Cancer Center Amsterdam (CCA), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Center for Gynecologic Oncology Amsterdam (CGOA), Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, Netherlands., Zijlmans HJMAA; Center for Gynecologic Oncology Amsterdam (CGOA), Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, Netherlands., van Trommel NE; Center for Gynecologic Oncology Amsterdam (CGOA), Netherlands Cancer Institute-Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, Netherlands., de Gruijl TD; Department of Medical Oncology Amsterdam UMC, Cancer Center Amsterdam (CCA), Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Jordanova ES; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam University Medical Center (UMC), Cancer Center Amsterdam (CCA), Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.

المصدر: Frontiers in immunology [Front Immunol] 2020 Dec 17; Vol. 11, pp. 596825. Date of Electronic Publication: 2020 Dec 17 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor* , Gene Expression*, B7-H1 Antigen/*genetics , Programmed Cell Death 1 Ligand 2 Protein/*genetics , Uterine Cervical Neoplasms/*genetics, Adult ; B7-H1 Antigen/metabolism ; DNA Copy Number Variations ; Female ; Genetic Loci ; High-Throughput Nucleotide Sequencing ; Humans ; Immunohistochemistry ; Immunophenotyping ; In Situ Hybridization, Fluorescence ; Middle Aged ; Programmed Cell Death 1 Ligand 2 Protein/metabolism ; Uterine Cervical Neoplasms/diagnosis ; Uterine Cervical Neoplasms/metabolism

المؤلفون: Rotman J; Cancer Center Amsterdam (CCA), Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Heeren AM; Cancer Center Amsterdam (CCA), Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Gassama AA; Cancer Center Amsterdam (CCA), Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Lougheed SM; Cancer Center Amsterdam (CCA), Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Pocorni N; Cancer Center Amsterdam (CCA), Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Stam AGM; Cancer Center Amsterdam (CCA), Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Bleeker MCG; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Zijlmans HJMAA; Center for Gynecologic Oncology Amsterdam (CGOA), The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, the Netherlands., Mom CH; Cancer Center Amsterdam (CCA), Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam (CCA), Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands., Kenter GG; Cancer Center Amsterdam (CCA), Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Center for Gynecologic Oncology Amsterdam (CGOA), The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), Amsterdam, the Netherlands., Jordanova ES; Cancer Center Amsterdam (CCA), Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Cancer Center Amsterdam (CCA), Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., de Gruijl TD; Cancer Center Amsterdam (CCA), Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands. TD.deGruijl@amsterdamumc.nl.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 15; Vol. 26 (14), pp. 3791-3802. Date of Electronic Publication: 2020 Mar 27.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*immunology , CD8-Positive T-Lymphocytes/*immunology , Carcinoma, Squamous Cell/*immunology , Dendritic Cells/*immunology , Uterine Cervical Neoplasms/*immunology, Adenocarcinoma/drug therapy ; Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Cervix Uteri/immunology ; Cervix Uteri/pathology ; Datasets as Topic ; Dendritic Cells/drug effects ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/immunology ; Female ; Gene Expression Profiling ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Lymphocyte Activation ; Lymphocytes, Tumor-Infiltrating/immunology ; Middle Aged ; Tumor Microenvironment/immunology ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/mortality ; Uterine Cervical Neoplasms/pathology ; beta Catenin/antagonists & inhibitors ; beta Catenin/metabolism

المؤلفون: Heeren AM; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center Amsterdam, Amsterdam, The Netherlands., van Luijk IF; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Lakeman J; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Pocorni N; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center Amsterdam, Amsterdam, The Netherlands., Kole J; Laboratory for Physiology, Institute for Cardiovascular Research, Amsterdam UMC, VU University Medical Center Amsterdam, Amsterdam, The Netherlands., de Menezes RX; Department of Epidemiology and Biostatistics, Amsterdam UMC, VU University Medical Center Amsterdam, Amsterdam, The Netherlands., Kenter GG; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., de Kroon CD; Department of Gynecology, Leiden University Medical Center, Leiden, The Netherlands., Jordanova ES; Department of Obstetrics and Gynecology, Center Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. e.jordanova@vumc.nl.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Nov; Vol. 68 (11), pp. 1759-1767. Date of Electronic Publication: 2019 Oct 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lymphocytes, Tumor-Infiltrating/*immunology , Neoadjuvant Therapy/*methods , T-Lymphocytes, Regulatory/*immunology , Uterine Cervical Neoplasms/*drug therapy , Uterine Cervical Neoplasms/*immunology, Adult ; Chemotherapy, Adjuvant ; Cisplatin/administration & dosage ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Paclitaxel/administration & dosage ; Pilot Projects ; Prognosis ; Retrospective Studies ; Uterine Cervical Neoplasms/pathology ; Young Adult

المؤلفون: Rotman J; Department of Obstetrics and Gynecology, Center for Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Koster BD; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Jordanova ES; Department of Obstetrics and Gynecology, Center for Gynecological Oncology Amsterdam (CGOA), Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Heeren AM; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. TD.deGruijl@vumc.nl.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Oct; Vol. 68 (10), pp. 1681-1688. Date of Electronic Publication: 2019 Apr 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy/*methods , Lymph Nodes/*immunology , Neoplasms/*therapy, Dendritic Cells/immunology ; Humans ; Macrophages/immunology ; Neoplasms/immunology

المؤلفون: Heeren AM; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Rotman J; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Stam AGM; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Pocorni N; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Gassama AA; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Samuels S; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Bleeker MCG; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Mom CH; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Zijlmans HJMAA; Center for Gynecologic Oncology Amsterdam (CGOA), The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Kenter GG; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Center for Gynecologic Oncology Amsterdam (CGOA), The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Jordanova ES; Center for Gynecologic Oncology Amsterdam (CGOA), Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. TD.deGruijl@vumc.nl.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Feb 12; Vol. 7 (1), pp. 43. Date of Electronic Publication: 2019 Feb 12.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*pharmacology , CD8-Positive T-Lymphocytes/*drug effects , Nivolumab/*pharmacology , Programmed Cell Death 1 Receptor/*immunology , T-Lymphocyte Subsets/*drug effects , Uterine Cervical Neoplasms/*immunology, Adult ; CD4-Positive T-Lymphocytes/drug effects ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; Female ; Humans ; Lymph Nodes/immunology ; Middle Aged ; Oncogene Proteins, Viral/immunology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Repressor Proteins/immunology ; T-Lymphocyte Subsets/immunology

المؤلفون: Ijsselsteijn ME; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands., Brouwer TP; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands., Abdulrahman Z; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands., Reidy E; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands., Ramalheiro A; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands., Heeren AM; Department of Gynaecology, Leiden University Medical Centre, Centre for Gynaecologic Oncology, Amsterdam, The Netherlands., Vahrmeijer A; Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands., Jordanova ES; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Gynaecology, Leiden University Medical Centre, Centre for Gynaecologic Oncology, Amsterdam, The Netherlands., de Miranda NF; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.

المصدر: The journal of pathology. Clinical research [J Pathol Clin Res] 2019 Jan; Vol. 5 (1), pp. 3-11. Date of Electronic Publication: 2018 Dec 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Blackwell Country of Publication: England NLM ID: 101658534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2056-4538 (Electronic) Linking ISSN: 20564538 NLM ISO Abbreviation: J Pathol Clin Res Subsets: MEDLINE

مواضيع طبية MeSH: Immunophenotyping*, Biomarkers, Tumor/*analysis , Lymphocytes, Tumor-Infiltrating/*pathology , Neoplasms/*pathology, Biomarkers, Tumor/genetics ; Fluorescent Antibody Technique/methods ; Humans ; Immunotherapy/methods ; Lymphocytes, Tumor-Infiltrating/metabolism ; Neoplasms/diagnosis ; Neoplasms/genetics ; Sequence Analysis, RNA/methods

المؤلفون: Heeren AM; Center Gynecological Oncology Amsterdam (CGOA), Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, Netherlands.; Cancer Center Amsterdam, Departments of Medical Oncology & Radiation Oncology, VU University Medical Center, Amsterdam, Netherlands., van Dijk I; Cancer Center Amsterdam, Departments of Medical Oncology & Radiation Oncology, VU University Medical Center, Amsterdam, Netherlands., Berry DRAI; Department of Pathology, VU University Medical Center, Amsterdam, Netherlands., Khelil M; Center Gynecological Oncology Amsterdam (CGOA), Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, Netherlands., Ferns D; Center Gynecological Oncology Amsterdam (CGOA), Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, Netherlands., Kole J; Laboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, Netherlands., Musters RJP; Laboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, Netherlands., Thijssen VL; Cancer Center Amsterdam, Departments of Medical Oncology & Radiation Oncology, VU University Medical Center, Amsterdam, Netherlands., Mom CH; Center Gynecological Oncology Amsterdam (CGOA), Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, Netherlands., Kenter GG; Center Gynecological Oncology Amsterdam (CGOA), Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, Netherlands.; Center Gynecological Oncology Amsterdam (CGOA), Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, Netherlands.; Center Gynecological Oncology Amsterdam (CGOA), Department of Gynecology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., Bleeker MCG; Department of Pathology, VU University Medical Center, Amsterdam, Netherlands., de Gruijl TD; Cancer Center Amsterdam, Departments of Medical Oncology & Radiation Oncology, VU University Medical Center, Amsterdam, Netherlands., Jordanova ES; Center Gynecological Oncology Amsterdam (CGOA), Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, Netherlands.

المصدر: Frontiers in immunology [Front Immunol] 2018 Jul 11; Vol. 9, pp. 1598. Date of Electronic Publication: 2018 Jul 11 (Print Publication: 2018).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE

المؤلفون: Ottenhof SR; Department of Urology, Netherlands Cancer Institute, Amsterdam, Netherlands., Djajadiningrat RS; Department of Urology, Netherlands Cancer Institute, Amsterdam, Netherlands.; Department of Urology, HagaZiekenhuis, Hague, Netherlands., Thygesen HH; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands.; Statistics, Department of Conservation, Hamilton, New Zealand., Jakobs PJ; Department of Urology, Netherlands Cancer Institute, Amsterdam, Netherlands., Jóźwiak K; Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, Netherlands., Heeren AM; Center for Gynecologic Oncology Amsterdam (CGOA), VU University Medical Center, Amsterdam, Netherlands., de Jong J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Sanders J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Horenblas S; Department of Urology, Netherlands Cancer Institute, Amsterdam, Netherlands., Jordanova ES; Center for Gynecologic Oncology Amsterdam (CGOA), VU University Medical Center, Amsterdam, Netherlands.

المصدر: Frontiers in immunology [Front Immunol] 2018 Jun 11; Vol. 9, pp. 1253. Date of Electronic Publication: 2018 Jun 11 (Print Publication: 2018).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol

مواضيع طبية MeSH: Carcinoma, Squamous Cell/*diagnosis , Carcinoma, Squamous Cell/*immunology , Penile Neoplasms/*diagnosis , Penile Neoplasms/*immunology , Tumor Microenvironment/*immunology, Aged ; B7-H1 Antigen/genetics ; B7-H1 Antigen/metabolism ; Biomarkers ; Follow-Up Studies ; Humans ; Immunologic Factors ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Macrophages/immunology ; Macrophages/metabolism ; Male ; Middle Aged ; Neoplasm Staging ; Netherlands ; Odds Ratio ; Papillomavirus Infections/classification ; Papillomavirus Infections/genetics ; Prognosis ; T-Lymphocytes, Cytotoxic